Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Change Healthcare Lawsuit Lawyers are reviewing Change Healthcare class action lawsuits for individuals who had their personal information stolen due to the data breach.
AngioDynamics Port Catheter Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Processed Food Lawsuit Lawsuits are being pursued against the food industry over their manufacturing and advertising of ultra-processed foods, which have caused a generation of children to face an increased risk of developing childhood diabetes and other chronic illnesses.
AFFF Lawsuit Exposure to firefighting foam chemicals may result in an increased risk of cancer for firefighters, military and airport personnel.
Paraquat Parkinson’s Disease Lawsuits Exposure to the toxic herbicide Paraquat has been linked to a risk of Parkinson's disease.
Philips Respironics Sets Aside Another $630M To Settle CPAP Recall Lawsuits The company says the money will help it reach its goal of beginning to settle Philips CPAP recall lawsuits within the next few months. April 25, 2023 Irvin Jackson Add Your Comments The parent company of Philips Respironics has earmarked $630 million in costs on a recent financial statement to settle certain CPAP recall lawsuits, which have been filed over the use of toxic sound abatement foam in its sleep apnea machines. Amsterdam-based Royal Philips announced its 2023 first-quarter earnings on Monday, indicating that the additional funds will help it reach a resolution to CPAP economic damage lawsuits filed on behalf of thousands of individuals in the U.S., who used recalled devices that exposed them to a risk of cancer, lung damage and other respiratory conditions. Following a CPAP recall issued in 2021, millions of consumers were told to immediately stop using their Philips machines, after the manufacturer acknowledged that the defective sound abatement foam inside the devices may degrade and breakdown, releasing toxic chemicals and small black particles directly into the machine’s air pathways and the lungs of users. Many experts predict that the manufacturer will ultimately face billions in legal liability and Philips CPAP settlement payouts, including any payments made to settle economic loss class action lawsuits that seek medical monitoring and damages associated with replacing or repair the machines, as well as substantially larger claims involving specific personal injuries experienced by former users. Stay Up-to-Date About Philips CPAP Recall Lawsuits AboutLawsuits.com sends a weekly digest email with information about recalls, lawsuits and warnings that may impact your family, which will include any new Philips CPAP recall lawsuit updates or developments. "*" indicates required fields Email* Δ Learn More Stay Up-to-Date About Philips CPAP Recall Lawsuits AboutLawsuits.com sends a weekly digest email with information about recalls, lawsuits and warnings that may impact your family, which will include any new Philips CPAP recall lawsuit updates or developments. "*" indicates required fields Email* Δ Learn More Given common questions of fact and law raised in Philips CPAP lawsuits filed throughout the federal court system, all cases have been centralized before Senior U.S. District Judge Joy Flowers Conti in the Western District of Pennsylvania for coordinated discovery and pretrial proceedings, as part of a multidistrict litigation (MDL). “Resolving the Philips Respironics recall for patients remains our highest priority. In the first quarter, we have recorded a provision in anticipation of a resolution of the economic loss class action in the US,” the company told investors in its 2023 Q1 earnings report, announcing the $630 million set aside. “This is an important step in addressing the litigation related to the recall.” The money is earmarked to specifically resolve economic loss claims, where CPAP users who have not claimed to have suffered physical injuries, but seek reimbursement for the devices and the cost of medical monitoring for future side effects that may be caused by exposure to the toxic sound abatement foam. Previously, the company had already set aside about $1 billion to handle the cost of recalling millions of devices and repairing and replacing them, but that did not include legal costs. Just last week, Philips CEO Roy Jakobs announced the company’s intent to settle Philips CPAP recall claims involving economic losses later this year. In addition, Jakobs indicated the company hopes to resolve individual personal injury lawsuits sometime in 2024; a cost likely to far exceed the economic loss settlement. Philips CPAP Recall Problems The $630 million set aside comes as the company faces criticism from federal regulators over how it has handled the recall and replacement of millions of devices. The Philips CPAP recall was first announced in June 2021, impacting millions of machines sold since 2009, which contain a defective polyester-based polyurethane (PE-PUR) foam. While the foam was intended to reduce noise and vibrations while the sleep apnea machines were used at night, it has been found to breakdown and release small black particles and chemicals directly into the machine’s air pathways and users’ lungs. As a result of the potential CPAP foam health risks, federal health officials immediately warned all consumers to stop using the recalled machines nearly two years ago, unless needed for life-sustaining therapy. The FDA has been extremely critical of Philips’ handling of the recall, at first warning that the company’s recall notifications had been inadequate, and that its CPAP repair program has been slow to get much-needed breathing assistance machines back to the consumers who need them. Earlier this month, the FDA warned consumers that Philips has issued deceptive information regarding how many repaired or replacement CPAP devices it has shipped to consumers. Philips initially announced the CPAP machine repair and replacement program in September 2021, but the pace of repairs has been extremely slow, along with some concerns about the safety of the alternative foam material the manufacturer is using, which may also release harmful chemicals directly into the machine’s air pathways. As of February 2023, the FDA indicated it was aware of nearly 100,00 medical device reports involving problems with Philips CPAP, BiPAP and ventilator devices, including reports of nearly 350 deaths. May 2023 Philips CPAP Lawsuit Settlement Update There are currently more than 300 lawsuits against Philips already filed in the federal court system, with thousands of additional CPAP injury claims registered on a census established by the court to toll the statute of limitations. Throughout 2023, the number of claims is expected to rapidly grow, both involving injuries diagnosed long before the recall, as well as new injuries that continue to be diagnosed months after users breathed the toxic particles released as the sound abatement foam degraded inside their machines. Negotiating Philips CPAP settlements for the injury claims will be more complex than the economic loss class action lawsuits, given the wide variety of different types of cancer and lung damage individual plaintiffs have alleged may be caused by the sleep apnea machines, including: Leukemia, Lymphoma or other Cancers Pulmonary Fibrosis, Sarcoidosis or other Lung Diseases Chronic Asthma, Bronchitis or Pneumonia Liver Injury, Kidney Injury, Heart Attack, Stroke or Heart Failure As part of the coordinated management of the litigation, Judge Conti has also directed the parties to establish a bellwether process, where small groups of representative claims will be prepared for early trial dates if Philips CPAP settlements can not be reached to resolve large numbers of claims. While the outcome of these early verdicts will not have any binding impact on other plaintiffs, the average Philips CPAP lawsuit payout amounts awarded by juries are likely to have a big influence on how much the manufacturer will pay to settle claims, to avoid each claim being remanded to different U.S. District Courts nationwide for separate trial dates in the future. However, a settlement agreement reached before then may make such trials unnecessary. Tags: Cancer, CPAP, CPAP Recall, Philips, Respiratory More Philips CPAP Recall Lawsuit Stories Lawsuits Between Philips and SoClean Over CPAP Machine Problems To Be Trial Ready by July 2025 September 3, 2024 Fairness Hearing For Philips CPAP Recall Medical Monitoring Settlement Set for October July 11, 2024 Philips OmniLab Advanced+ Ventilator Recall Issued Over Loss of Therapy Risks July 1, 2024 0 Comments Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA TermNameThis field is for validation purposes and should be left unchanged. Δ MORE TOP STORIES Depo-Provera Meningioma Diagnosis Information Required To Qualify for Lawsuit: Order (Posted: today) Women pursuing Depo-Provera meningioma lawsuits will have to provide documentary proof of their diagnosis and the versions of the birth control shot they received within 120 days of filing their case. MORE ABOUT: DEPO-PROVERA LAWSUITDepo-Provera Lawsuit Timeline for Preparing Pilot Trial Cases Outlined by MDL Judge (03/24/2025)Women Can File Depo-Provera Brain Tumor Lawsuits Directly in MDL: Court Order (03/18/2025)75 Lawyers in Depo-Provera Lawsuits Seek MDL Leadership Roles (03/10/2025) Cartiva SCI Lawsuit Alleges Toe Implant Worsened Pain, Decreased Range of Motion (Posted: yesterday) An Indiana woman has filed a Cartiva SCI implant lawsuit, indicating that the toe implant failed due to a defective design, resulting in the need for revision surgery and recommendations to permanently fuse her big toe. MORE ABOUT: CARTIVA IMPLANT LAWSUITCartiva Implant Injury Lawsuit Set for Trial in February 2026 (03/07/2025)Lawsuit Indicates Cartiva Implant Fails in 2 Out of 3 Patients, But Continued To Be Sold in U.S. (02/13/2025)Cartiva Toe Implant Lawsuit Filed Over Worsened Pain, Reduced Range of Motion and Need for Surgical Removal (02/07/2025) Salon Professionals Claim Occupational Exposure to Hair Dye Products Caused Bladder Cancer: Lawsuits (Posted: 4 days ago) Two California hair stylists filed separate lawsuits, indicating that repeated occupational exposure to toxic chemicals in hair coloring dyes caused them to develop bladder cancer. MORE ABOUT: HAIR DYE LAWSUITHair Color Lawsuit Filed Over Salon Worker’s Bladder Cancer Diagnosis (03/20/2025)Brazilian Blowout Cancer Lawsuit Filed by Missouri Hair Stylists Over Exosure to Toxic Chemicals (03/11/2025)Initial Status Conference for Hair Dresser’s Bladder Cancer Lawsuit Set for May 5 (03/10/2025)
Lawsuits Between Philips and SoClean Over CPAP Machine Problems To Be Trial Ready by July 2025 September 3, 2024
Depo-Provera Meningioma Diagnosis Information Required To Qualify for Lawsuit: Order (Posted: today) Women pursuing Depo-Provera meningioma lawsuits will have to provide documentary proof of their diagnosis and the versions of the birth control shot they received within 120 days of filing their case. MORE ABOUT: DEPO-PROVERA LAWSUITDepo-Provera Lawsuit Timeline for Preparing Pilot Trial Cases Outlined by MDL Judge (03/24/2025)Women Can File Depo-Provera Brain Tumor Lawsuits Directly in MDL: Court Order (03/18/2025)75 Lawyers in Depo-Provera Lawsuits Seek MDL Leadership Roles (03/10/2025)
Cartiva SCI Lawsuit Alleges Toe Implant Worsened Pain, Decreased Range of Motion (Posted: yesterday) An Indiana woman has filed a Cartiva SCI implant lawsuit, indicating that the toe implant failed due to a defective design, resulting in the need for revision surgery and recommendations to permanently fuse her big toe. MORE ABOUT: CARTIVA IMPLANT LAWSUITCartiva Implant Injury Lawsuit Set for Trial in February 2026 (03/07/2025)Lawsuit Indicates Cartiva Implant Fails in 2 Out of 3 Patients, But Continued To Be Sold in U.S. (02/13/2025)Cartiva Toe Implant Lawsuit Filed Over Worsened Pain, Reduced Range of Motion and Need for Surgical Removal (02/07/2025)
Salon Professionals Claim Occupational Exposure to Hair Dye Products Caused Bladder Cancer: Lawsuits (Posted: 4 days ago) Two California hair stylists filed separate lawsuits, indicating that repeated occupational exposure to toxic chemicals in hair coloring dyes caused them to develop bladder cancer. MORE ABOUT: HAIR DYE LAWSUITHair Color Lawsuit Filed Over Salon Worker’s Bladder Cancer Diagnosis (03/20/2025)Brazilian Blowout Cancer Lawsuit Filed by Missouri Hair Stylists Over Exosure to Toxic Chemicals (03/11/2025)Initial Status Conference for Hair Dresser’s Bladder Cancer Lawsuit Set for May 5 (03/10/2025)